OrganiGram Holdings Inc. (NASDAQ:OGI) Q2 2022 Earnings Conference Call April 12, 2022 8:00 AM ET Company Participants Craig MacPhail - Group Director, NATIONAL Capital Markets Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets Matt Bottomley - Canaccord Genuity Douglas Miehm - RBC Capital Markets Ty Collin - Eight Capital Frederico Gomes - ATB Capital Markets Owen Bennett - Jeffe ...

TABLE OF CONTENTS | Condensed Consolidated Interim Statements of Financial Position | 1 | | --- | --- | | Condensed Consolidated Interim Statements of Operations and Comprehensive Loss | 2 | | Condensed Consolidated Interim Statements of Changes in Equity | 3 | | Condensed Consolidated Interim Statements of Cash Flows | 4 | | Notes to the Condensed Consolidated Interim Financial Statements | 5 – 30 | ORGANIGRAM HOLDINGS INC. CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION As at February 28, ...

TABLE OF CONTENTS | Condensed Consolidated Interim Statements of Financial Position | | 1 | | --- | --- | --- | | Condensed Consolidated Interim Statements of Operations and Comprehensive Loss | | 2 | | Condensed Consolidated Interim Statements of Changes in Equity | | 3 | | Condensed Consolidated Interim Statements of Cash Flows | | 4 | | Notes to the Condensed Consolidated Interim Financial Statements | 5 – | 26 | ORGANIGRAM HOLDINGS INC. CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION As ...

Financial Data and Key Metrics Changes - The first quarter of fiscal 2022 achieved record net revenue of $30.4 million, a 57% increase compared to Q1 fiscal 2021 [9][25] - Gross revenue grew 75% year-over-year to $44.3 million, primarily driven by higher recreational net revenue [25] - Cost of sales increased only 21% year-over-year to $28 million, leading to an improved gross margin of $610,000 compared to a loss of $16.7 million in Q1 2021 [27][25] - The adjusted EBITDA loss was reduced from $5.7 million in Q1 2021 to $1.9 million in Q1 2022, with a net loss decreasing from $34.3 million to $1.3 million [28][29] Business Line Data and Key Metrics Changes - The SHRED brand continued to be the most popular flower brand, with significant sales growth and market share increase [10][11] - SHRED'ems gummies ranked number three in sales and volume of units sold shortly after their introduction [12] - The Edison brand maintained strong market share, with new high potency strains launched to meet consumer demand [15] Market Data and Key Metrics Changes - OrganiGram held a 7.5% market share in the Canadian recreational market, up from 4.4% a year ago [9] - Market share increased to 7.6% in December, with the company holding the number one position in the flower category and moving up in gummies and pre-rolls [13] - The legal market now accounts for 53% of sales compared to 47% for the illicit market, indicating a shift in consumer preference [100] Company Strategy and Development Direction - The company completed an acquisition of Laurentian, enhancing its product portfolio and geographic presence in Quebec [8][24] - Investment in Hyasynth Biologicals was increased to $10 million, aiming to leverage biosynthesis for cannabinoid production [20][21] - The company plans to expand its capacity to 75,000 kilograms annually, which is expected to improve margins and meet growing demand [44][81] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about achieving positive adjusted EBITDA by Q3 of fiscal 2022, supported by the Laurentian acquisition [29] - The company is cautious about Q2 due to seasonal factors and potential COVID-related restrictions impacting retail operations [66] - Management noted sustained demand for the SHRED brand and the importance of expanding distribution to meet consumer needs [49] Other Important Information - The company harvested approximately 11,600 kilograms of flower in Q1 2022, a 197% increase from the prior year [26] - The acquisition of Laurentian is expected to add $17 million in annual net revenue and $6 million in EBITDA [24] - The company is exploring international expansion opportunities, including potential markets in Europe and Australia [102] Q&A Session Summary Question: What drove the significant increase in market share? - Management attributed the growth to increased consumer interest in the SHRED brand and successful product launches in the gummies category [37][38] Question: What is unique about the Laurentian Organics acquisition? - Laurentian focuses on premium hash products with strong margins, which has driven consumer appreciation [39][40] Question: What is the outlook for Q2 sales? - Management indicated that Q2 is typically the lowest quarter due to seasonal factors, but expects significant year-over-year growth [64][66] Question: How does the company view pricing pressure in the market? - Management noted that while there has been price compression in the flower category, they have maintained pricing on SHRED due to strong demand [59][60] Question: What is the company's strategy for the U.S. market? - The company is monitoring U.S. market developments and will explore opportunities when the timing is right, focusing on CBD offerings and other adjacencies [107]

ORGANIGRAM INVESTOR PRESENTATION Q1 FISCAL 2022 LORGANIGRAM NASDAQ (OGI) TSX (OGI) CAUTIONARY STATEMENT This document is current as of January 11, 2022, except where otherwise stated. The information contained in this presentation is provided by Organigram Holdings Inc. ("Organigram" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of Organigram or other financial products. No part of this pr ...

OrganiGram Holdings Inc. (NASDAQ:OGI) Q4 2021 Earnings Conference Call November 23, 2021 8:00 AM ET Company Participants | --- | |-----------------------------------------------------------------------------------| | | | | | Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer | | Conference Call Participants | | Frederico Gomes - ATB | | Rahul Sarugaser - Raymond James | | Rupesh Parikh - Oppenheimer | | | | Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets ...

ORGANIGRAM INVESTOR PRESENTATION (UPDATED: Q4 FISCAL 2021) NASDAQ (OGI) TSX (OGI) CORGANIGRAM CAUTIONARY STATEMENT This document is current as of November 22, 2021, except where otherwise stated. The information contained in this presentation is provided by Organigram ("OGI" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of OGI or other financial products. No part of this presentation shall ...

OrganiGram Holdings Inc. (NASDAQ:OGI) Q3 2021 Earnings Conference Call July 13, 2021 8:00 AM ET Company Participants Amy Schwalm - Vice President, Investor Relations Derrick West - Chief Financial Officer Paolo De Luca - Chief Strategy Officer Conference Call Participants David Kideckel - ATB Capital Markets Andrew Partheniou - Stifel GMP Tamy Chen - BMO Capital Markets Adam Buckham - Scotiabank Rupesh Parikh - Oppenheimer John Zamparo - CIBC Operator Good morning. My name is Renz and I will be your operato ...

ORGANIGRAM INVESTOR PRESENTATION NASDAQ (OGI) TSX (OGI) L ORGANIGRAM CAUTIONARY STATEMENT This document is current as of June 6, 2021, except where otherwise stated. The information contained in this presentation is provided by Organigram ("OGI" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of OGI or other financial products. No part of this presentation shall form the basis or be relied u ...

OrganiGram Holdings Inc. (NASDAQ:OGI) Q2 2021 Earnings Conference Call April 13, 2021 8:00 AM ET Company Participants Amy Schwalm - Vice President, Investor Relations Greg Engel - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Andrew Partheniou - Stifel David Kideckel - ATB Capital Markets Tamy Chen - BMO John Zamparo - CIBC Madeleine Stone - Oppenheimer Aaron Grey - Alliance Global Partners Graeme Kindler - Eight Capital Rahul Sarugaser - Raymond James Douglas M ...